281 related articles for article (PubMed ID: 22407829)
1. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities.
Perez-Moreno P; Brambilla E; Thomas R; Soria JC
Clin Cancer Res; 2012 May; 18(9):2443-51. PubMed ID: 22407829
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.
Ocque R; Tochigi N; Ohori NP; Dacic S
Am J Clin Pathol; 2011 Jul; 136(1):81-7. PubMed ID: 21685035
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations defining NSCLC subtypes and their therapeutic implications.
Pikor LA; Ramnarine VR; Lam S; Lam WL
Lung Cancer; 2013 Nov; 82(2):179-89. PubMed ID: 24011633
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
Ohtsuka K; Ohnishi H; Fujiwara M; Kishino T; Matsushima S; Furuyashiki G; Takei H; Koshiishi Y; Goya T; Watanabe T
Cancer; 2007 Feb; 109(4):741-50. PubMed ID: 17238183
[TBL] [Abstract][Full Text] [Related]
6. Squamous-cell carcinoma of the lungs: is it really so different?
Sereno M; Esteban IR; Zambrana F; Merino M; Gómez-Raposo C; López-Gómez M; Sáenz EC
Crit Rev Oncol Hematol; 2012 Dec; 84(3):327-39. PubMed ID: 22819280
[TBL] [Abstract][Full Text] [Related]
7. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
8. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
[TBL] [Abstract][Full Text] [Related]
10. The importance of pathology for prognosis and management in lung cancer.
Yesner R
Conn Med; 1975 May; 39(5):280-3. PubMed ID: 165034
[No Abstract] [Full Text] [Related]
11. Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologies.
Gerber DE; Paik PK; Dowlati A
Am Soc Clin Oncol Educ Book; 2015; ():147-62. PubMed ID: 25993153
[TBL] [Abstract][Full Text] [Related]
12. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence.
Tai AL; Yan WS; Fang Y; Xie D; Sham JS; Guan XY
Cancer; 2004 May; 100(9):1918-27. PubMed ID: 15112273
[TBL] [Abstract][Full Text] [Related]
13. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
Bastide K; Ugolin N; Levalois C; Bernaudin JF; Chevillard S
Lung Cancer; 2010 Apr; 68(1):1-9. PubMed ID: 20004040
[TBL] [Abstract][Full Text] [Related]
14. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.
Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A
Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671
[TBL] [Abstract][Full Text] [Related]
15. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
[TBL] [Abstract][Full Text] [Related]
16. [Pathological variability and cancer treatment in lung cancer].
Kodama T
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250
[TBL] [Abstract][Full Text] [Related]
17. Common and contrasting genomic profiles among the major human lung cancer subtypes.
Tonon G; Brennan C; Protopopov A; Maulik G; Feng B; Zhang Y; Khatry DB; You MJ; Aguirre AJ; Martin ES; Yang Z; Ji H; Chin L; Wong KK; Depinho RA
Cold Spring Harb Symp Quant Biol; 2005; 70():11-24. PubMed ID: 16869734
[TBL] [Abstract][Full Text] [Related]
18. Assessment of molecular events in squamous and non-squamous cell lung carcinoma.
Yakut T; Schulten HJ; Demir A; Frank D; Danner B; Egeli U; Gebitekin C; Kahler E; Gunawan B; Urer N; Oztürk H; Füzesi L
Lung Cancer; 2006 Dec; 54(3):293-301. PubMed ID: 17011066
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer: progress in diagnosis and treatment.
Carney DN
Ir Med J; 1984 Oct; 77(10):327-9. PubMed ID: 6094392
[No Abstract] [Full Text] [Related]
20. Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review.
Field RW; Smith BJ; Platz CE; Robinson RA; Neuberger JS; Brus CP; Lynch CF
J Natl Cancer Inst; 2004 Jul; 96(14):1105-7. PubMed ID: 15265973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
